Clinical potential of nintedanib for the second-line treatment of advanced non-small-cell lung cancer: current evidence
Sacha I Rothschild Department of Internal Medicine, Medical Oncology, University Hospital Basel, Basel, Switzerland Abstract: The therapeutic landscape in non-small-cell lung cancer (NSCLC) is changing. The description of molecular alterations leading to NSCLC carcinogenesis and progression (so-ca...
Enregistré dans:
| Auteur principal: | |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Dove Medical Press
2014
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/5b909e68f466420d993c0859e0797d53 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|